APA (7th ed.) Citation

VB, S., AL, S., A, H., J, H., B, D., MC, E., . . . MG, T. (2021). Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(4), 699. https://doi.org/10.1158/1055-9965.EPI-20-0604

Chicago Style (17th ed.) Citation

VB, Sheppard, Sutton AL, Hurtado-de-Mendoza A, He J, Dahman B, Edmonds MC, Hackney MH, and Tadesse MG. "Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study." Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 30, no. 4 (2021): 699. https://doi.org/10.1158/1055-9965.EPI-20-0604.

MLA (9th ed.) Citation

VB, Sheppard, et al. "Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study." Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 30, no. 4, 2021, p. 699, https://doi.org/10.1158/1055-9965.EPI-20-0604.